Abstract
We describe a 72-year-old woman who was diagnosed with asymptomatic multiple myeloma (MM) while being treated for Philadelphia (Ph)-positive chronic myeloid leukemia (CML) with imatinib mesylate (400 mg/day). The diagnosis of CML was based on the presence of the Ph chromosome and chimeric BCR-ABL messenger RNA. Three months after starting imatinib mesylate treatment, the patient achieved a complete cytogenetic response. However, bone marrow analysis at that time demonstrated plasmacytosis, and paraprotein (IgG, κ-type) was also detected. Hypercalcemia, renal failure, anemia, and bone lesions were not observed, which suggested that asymptomatic MM had developed. The coexistence of CML and MM is an extremely uncommon event that has only been reported in 12 cases. We discuss the relationship between CML and MM.
Similar content being viewed by others
References
Wakayama T, Fujita S, Ago H. An elder patient coexisted with multiple myeloma and chronic myeloid leukemia before treatments. Med J Shimane Pref Cent Hosp. 2005;29:63–7.
Schwarzmeier JD, Shehata M, Ackermann J, Hilgarth M, Kaufmann H, Drach J. Simultaneous occurrence of chronic myeloid leukemia and multiple myeloma: evaluation by FISH analysis and in vitro expansion of bone marrow cells. Leukemia. 2003;17:1426–8.
Tanaka M, Kimura R, Matsutani A, Zaitsu K, Oka Y, Oizumi K. Coexistence of chronic myelogenous leukemia and multiple myeloma. Case report and review of the literature. Acta Haematol. 1998;99:221–3.
Boots MA, Pegrum GD. Simultaneous presentation of chronic granulocytic leukaemia and multiple myeloma. J Clin Pathol. 1982;35:364–5.
Galanopoulos A, Papadhimitriou SI, Kritikou-Griva E, Georgiakaki M, Anagnostopoulos NI. Multiple myeloma developing after imatinib mesylate therapy for chronic myeloid leukemia. Ann Hematol. 2009;88:281–2.
Garipidou V, Vakalopoulou S, Tziomalos K. Development of multiple myeloma in a patient with chronic myeloid leukemia after treatment with imatinib mesylate. Oncologist. 2005;10:457–8.
Yokota A, Onoda M, Uehara T, Terano T. Coexistence of chronic myelogenous leukemia and multiple myeloma. Rinsho Ketsueki. 2005;46:919.
Derghazarian C, Whittemore NB. Multiple myeloma superimposed on chronic myelocytic leukemia. Can Med Assoc J. 1974;110:1047–50.
Nakagawa M, Noto S, Kobayashi H, Hayashi M. A case of a 47-year-old man who developed chronic myelogenous leukemia after therapy for multiple myeloma. J Obihiro Kosei Gen Hosp. 2003;6:101–6.
Nitta M, Tsuboi K, Yamashita S, Kato M, Hayami Y, Harada S, et al. Multiple myeloma preceding the development of chronic myelogenous leukemia. Int J Hematol. 1999;69:170–3.
Klenn PJ, Hyun BH, Lee YH, Zheng WY. Multiple myeloma and chronic myelogenous leukemia-a case report with literature review. Yonsei Med J. 1993;34:293–300.
MacSween JM, Langley GR. Light-chain disease (hypogammaglobulinemia and Bence Jones proteinuria) and sideroblastic anemia-preleukemic chronic granulocytic leukemia. Can Med Assoc J. 1972;106:995–8.
International Myeloma Working Group. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol. 2003;121:749–57.
Standen GR, Jasani B, Wagstaff M, Wardrop CA. Chronic neutrophilic leukemia and multiple myeloma. An association with lambda light chain expression. Cancer. 1990;66:162–6.
Lewis MJ, Oelbaum MH, Coleman M, Allen S. An association between chronic neutrophilic leukaemia and multiple myeloma with a study of cobalamin-binding proteins. Br J Haematol. 1986;63:173–80.
Naparstek Y, Zlotnick A, Polliack A. Coexistent chronic myeloid leukemia and IgA monoclonal gammopathy: report of a case and review of the literature. Am J Med Sci. 1980;279:111–5.
Vorobiof DA, Benjamin J, Kaplan H, Dvilansky A. Chronic granulocytic leukemia, neutrophilic type, with paraproteinemia (IgA type K). Acta Haematol. 1978;60:316–20.
Shoenfeld Y, Berliner S, Ayalone A, Shaklai M, Djaldetti M, Pick AI, et al. Monoclonal gammopathy in patients with chronic and acute myeloid leukemia. Cancer. 1984;54:280–3.
Ritzmann SE, Stoufflet EJ, Houston EW, Levin WC. Coexistent chronic myelocytic leukemia, monoclonal gammopathy and multiple chromosomal abnormalities. Am J Med. 1966;41:981–9.
Maeda K, Abraham J. Polycythemia associated with myeloma. Am J Clin Pathol. 1984;82:501–5.
Heinle EW Jr, Sarasti HO, Garcia D, Kenny JJ, Westerman MP. Polycythemia vera associated with lymphomatous diseases and myeloma. Arch Intern Med. 1966;118:351–5.
Brody JI, Beizer LH, Schwartz S. Multiple myeloma and the myeloproliferative syndromes. Am J Med. 1964;36:315–9.
Cobo F, Cervantes F, Martinez C, Salgado C, Blade J, Montserrat E, et al. Multiple myeloma following essential thrombocythemia. Leuk Lymphoma. 1995;20:177–9.
Selroos O, van Assendelft A. Thrombocythaemia and multiple myeloma. A report on two cases. Acta Med Scand. 1977;201:243–7.
Kasimis BS, Yen-Lin R, Neiman RS. Multiple myeloma associated with myelofibrosis. Report of a case and literature review. Oncology. 1981;38:369–72.
Tzilves D, Gatopoulou A, Zervas K, Katodritou E, Patakiouta F, Tarpagos A, et al. Development of multiple myeloma in a patient with gastrointestinal stromal tumor treated with imatinib mesylate: a case report. World J Gastroenterol. 2007;13:2011–3.
Pandiella A, Carvajal-Vergara X, Tabera S, Mateo G, Gutiérrez N, San Miguel JF. Imatinib mesylate (STI571) inhibits multiple myeloma cell proliferation and potentiates the effect of common antimyeloma agents. Br J Haematol. 2003;123:858–68.
Dispenzieri A, Gertz MA, Lacy MQ, Geyer SM, Greipp PR, Rajkumar SV, et al. A phase II trial of imatinib in patients with refractory/relapsed myeloma. Leuk Lymphoma. 2006;47:39–42.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Ide, M., Kuwahara, N., Matsuishi, E. et al. Uncommon case of chronic myeloid leukemia with multiple myeloma. Int J Hematol 91, 699–704 (2010). https://doi.org/10.1007/s12185-010-0546-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12185-010-0546-4